APM - Aptorum Group Limited Class A Ordinary Shares

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.59 -0.04 (-2.52%)	---	---	0.0 (0.0%)	-0.03 (-1.89%)	-0.03 (-1.87%)	-0.02 (-1.27%)	-0.02 (-1.27%)

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Category: /stock/categories/na

Market Period: AfterHours

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:: 3.18
VWAP:: 1.55
RVol:: 0.3481

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	1.59 -0.05 (-3.05%)	Oct 15 08:36
10m	Price decrease 10m	1.59 -0.05 (-3.05%)	Oct 15 08:36
1m	Price increase 1m	1.63 +0.04 (+2.52%)	Oct 15 07:02